안국약품

001540KOSDAQ

57.5 / 100

Reference Date: 2026-10-23

Financial Score28.0 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PBR is significantly undervalued vs. peers is also solid. Declined 8.9% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

AnKook Pharmaceuticals, established in 1959, is a company specializing in the production and sale of pharmaceuticals and health functional foods, with key products including Sinechura and Levotension. In 2022, sales increased by 16% year-on-year to 271.1 billion KRW, and operating profit rose 32.4% to 6.7 billion KRW, driven by strong market share in respiratory and circulatory drug segments. The company is expanding into AI medical devices and online sales through 'Ewonther' to diversify its business.

Number of Employees

424people

Average Salary

58.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

14.19Industry Average 15.005.0Point

In line with industry avg

PBR

0.73Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

4.42Industry Average 8.002.5Point

Below industry avg

Debt Ratio

37.13Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲14.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲39.5% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 5.1% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (34%)

Current 9,340Won52-week high 13,25052-week low 7,280

1-month return1.0Point

1m -8.88% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-10-21
Neutral주요사항보고서(유형자산양수결정)2026-10-15